Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,122 | -3,563 | -8,484 | -9,279 | -5,718 |
| Depreciation Amortization | 31 | 14 | 38 | 24 | 12 |
| Other Working Capital | 886 | 971 | 944 | 251 | -139 |
| Other Operating Activity | 47 | 14 | -4,351 | 794 | 24 |
| Operating Cash Flow | $-6,158 | $-2,564 | $-11,853 | $-8,210 | $-5,821 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -24 | -24 | -24 |
| Investing Cash Flow | $N/A | $N/A | $-24 | $-24 | $-24 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38 | 38 | 16,897 | 16,792 | 15,835 |
| Other Financing Activity | -23 | -9 | -14 | 0 | 0 |
| Financing Cash Flow | $15 | $28 | $16,884 | $16,792 | $15,835 |
| Exchange Rate Effect | -454 | -630 | 638 | 737 | -136 |
| Beginning Cash Position | 18,029 | 17,957 | 12,205 | 12,129 | 12,448 |
| End Cash Position | 11,432 | 14,792 | 17,850 | 21,423 | 22,302 |
| Net Cash Flow | $-6,598 | $-3,165 | $5,645 | $9,295 | $9,855 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,158 | -2,564 | -11,853 | -8,210 | -5,821 |
| Capital Expenditure | N/A | N/A | -24 | -24 | -24 |
| Free Cash Flow | -6,158 | -2,564 | -11,877 | -8,234 | -5,845 |